Hikma Pharmaceuticals Regulatory News (HIK)

14 May 2007 16:42

Hikma Pharmaceuticals Plc14 May 2007 Annual Information Update LONDON, 14 May 2007. In accordance with Prospectus Rule 5.2, HikmaPharmaceuticals PLC ("Hikma" or "the Company")(LSE: HIK) (DIFX: HIK) sets outbelow a summary of the information which has been published or made available tothe public over the previous 12 months. The information referred to in thisUpdate was up to date at the time the information was published, but someinformation may now be out of date. Stock Exchange announcements Announcements made by the Company via RNS, a Regulatory Information Service, maybe viewed and downloaded from the London Stock Exchange website (www.londonstockexchange.com/marketnews) or from the press releases page on theCompany's website at (http://investors.hikma.com/hikma/regulatorynews.jsp). TheLondon Stock Exchange announcements made during the defined period are: Date of announcement Headline of announcement23 Apr 07 Hikma appoints new CEO20 Apr 07 Hikma acquires Thymoorgan05 Apr 07 Block Listing 6-month review05 Apr 07 Notification of transaction03 Apr 07 LTIP awards03 Apr 07 Notification of transaction03 Apr 07 Notification of transaction03 Apr 07 Notification of transaction03 Apr 07 Notification of transaction03 Apr 07 Notification of transaction02 Apr 07 Notification of transaction02 Apr 07 Notification of transaction02 Apr 07 Notification of transaction02 Apr 07 Voting rights and capital23 Mar 07 Interest in shares22 Mar 07 Final Results - Part 322 Mar 07 Final Results - Part 222 Mar 07 Final Results - Part 126 Jan 07 Completion of Acquisition22 Jan 07 Hikma enters oncology market18 Jan 07 Pre-close Trading Statement21 Dec 06 Voting rights and capital12 Dec 06 New board appointment06 Dec 06 Director's Commitments27 Nov 06 Notification of Transaction22 Nov 06 Renewal of Contract20 Nov 06 Notification of Site Visit08 Nov 06 Notification of transaction03 Nov 06 Section 198 Notification27 Oct 06 Section 198 Notification24 Oct 06 Trading update09 Oct 06 Block Listing 6-month review03 Oct 06 Notification of transaction13 Sep 06 Interim Results 2006 - Part 113 Sep 06 Interim Results 2006 - Part 313 Sep 06 Interim Results 2006 - Part 211 Sep 06 Completion of Acquisition13 Jul 06 Section 198 Notification13 Jul 06 Pre-close Statement21 Jun 06 Director Transaction12 Jun 06 Section 198 Notification31 May 06 Director Transaction25 May 06 Results of AGM25 May 06 AGM Trading Statement24 May 06 Section 198 Notification10 May 06 Hikma releases info on DIFX27 Apr 06 Director/PDMR Shareholding All of the above announcements were also made by the Company via the DubaiInternational Financial Exchange ("DIFX") CANDI system. These announcements maybe viewed and downloaded from the DIFX website (www.difx.ae). Additional DIFXannouncements made during the defined period are: 26 Apr 2007 Notice of Annual Report and Accounts Documents filed with the Financial Services Authority The company has filed the following documents with the Financial ServicesAuthority ("FSA") over the previous 12 months. These documents are or will beavailable to be viewed via the FSA's Document Viewing Facility or at theCompany's registered office. Date filed with the FSA Document filed with the FSA26 Apr 2007 2006 Annual Report and Accounts26 Apr 2007 Notice of Annual General Meeting Documents filed with Companies House The Company has made the following filings with Companies House. Copies of thesedocuments may be obtained from Companies House, Crown Way, Maindy, Cardiff CF143UZ or, if you are a registered user, they may be viewed and downloaded usingCompanies House Direct at www.direct.companieshouse.gov.uk. The Companies Housefilings made during the defined period are: Date filed with Companies Document filed with Companies HouseHouse3 May 2007 2006 Annual Report and Accounts18 Apr 2007 Form 88(2) - Return of Allotment of Shares18 Apr 2007 Form 88(2) - Return of Allotment of Shares18 Apr 2007 Form 88(2) - Return of Allotment of Shares11 Apr 2007 Form 88(2) - Return of Allotment of Shares7 Feb 2007 Form 88(2) - Return of Allotment of Shares7 Feb 2007 Form 88(2) - Return of Allotment of Shares4 Jan 2007 Form 288a - Appointment of Director12 Oct 2006 Form 88(2) - Return of Allotment of Shares27 Sep 2006 Form 363s - Annual Return13 Sep 2006 Interim Unaudited Accounts12 July 2006 Form 88(2) - Return of Allotment of Shares12 July 2006 Form 88(2) - Return of Allotment of Shares25 May 2006 Form 287 - Change of registered office25 May 2006 Ordinary and special resolutions passed at AGM23 May 2006 2005 Annual Report and Accounts17 May 2006 Form 88(2) - Return of Allotment of Shares17 May 2006 Form 88(2) - Return of Allotment of Shares Henry KnowlesCompany Secretary14 May 2007 - ENDS - Enquiries: Hikma Pharmaceuticals plc +44 20 7399 2760Henry Knowles, Company SecretarySusan Ringdal, Investor Relations DirectorBrunswick Group LLP +44 20 7404 5959Jon Coles / Justine McIlroy / Alex Tweed Notes to Editors About HikmaHikma Pharmaceuticals PLC is a multinational pharmaceutical group focused ondeveloping, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products. Hikma's operations are conducted through three businesses: Generic, Branded and Injectable Pharmaceuticals. Hikma's operations are based principally in the Middle Eastand North Africa ("MENA") region, the United States and Europe. In 2006, theGroup had revenue of $317 million and profit attributable to shareholders of $55 million. At 31 December 2006, the Group had over 2,443 employees. For news and other information, please visit www.hikma.com. This information is provided by RNS The company news service from the London Stock Exchange